Predictors of steroid non-response and new approaches in severe alcoholic hepatitis
Shiv Kumar Sarin, Shvetank Sharma
Clin Mol Hepatol. 2020;26(4):639-651.   Published online 2020 Oct 1     DOI: https://doi.org/10.3350/cmh.2020.0196
Citations to this article as recorded by Crossref logo
Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis
Ankur Jindal, Manoj K. Sharma, Rajan Vijayaraghavan, Shasthry SM, Guresh Kumar, Shiv K. Sarin
Digestive Diseases and Sciences.2024; 69(1): 298.     CrossRef
Real-World Utilization of Corticosteroids in Severe Alcoholic Hepatitis: Eligibility, Response, and Outcomes
Ana-Maria Singeap, Horia Minea, Oana Petrea, Madalina-Andreea Robea, Ioana-Miruna Balmuș, Raluca Duta, Ovidiu-Dumitru Ilie, Carmen Diana Cimpoesu, Carol Stanciu, Anca Trifan
Medicina.2024; 60(2): 311.     CrossRef
Quercetin alleviates ethanol‐induced hepatic steatosis in L02 cells by activating TFEB translocation to compensate for inadequate autophagy
Xingtao Zhao, Xinyan Xue, Jing Wang, Shu Dai, Cheng Peng, Yunxia Li
Phytotherapy Research.2023; 37(1): 62.     CrossRef
Patients with a History of Bariatric Surgery Are 8 Years Younger at Presentation with Severe Alcoholic Hepatitis
Lukas Van Melkebeke, Annelotte G. C. Broekhoven, Tessa Ostyn, Hannelie Korf, Minneke J. Coenraad, Roman Vangoitsenhoven, Bart Van der Schueren, Matthias Lannoo, Hannah Van Malenstein, Tania Roskams, Schalk van der Merwe, Frederik Nevens, Jef Verbeek
Obesity Surgery.2023; 33(1): 284.     CrossRef
AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study
Rakhi Maiwall, Samba Siva Rao Pasupuleti, Ashok Choudhury, Dong Joon kim, Ajit Sood, Omesh Goyal, Vandana Midha, Harshad Devarbhavi, Anil Arora, Ashish Kumar, Manoj Kumar Sahu, Sudhir Maharshi, Ajay Kumar Duseja, Virendra Singh, Sunil Taneja, P. N. Rao, A
Hepatology International.2023; 17(3): 662.     CrossRef
Management of alcoholic hepatitis: A clinical perspective
Philipp Kasper, Sonja Lang, Hans‐Michael Steffen, Münevver Demir
Liver International.2023; 43(10): 2078.     CrossRef
Efficiency of glucocorticosteroids in severe alcoholic hepatitis
A. S. Rodina, I. V. Kurbatova, M. E. Shubina, O. P. Dudanova
Meditsinskiy sovet = Medical Council.2023; (8): 135.     CrossRef
Past, Present, and Future Therapies for Alcohol-associated Hepatitis
Sally Condon, Loretta L. Jophlin
Clinical Therapeutics.2023; 45(12): 1171.     CrossRef
Mesenchymal stem cells-based therapy in liver diseases
Heng-Tong Han, Wei-Lin Jin, Xun Li
Molecular Biomedicine.2022;[Epub]     CrossRef
Can granulocyte colony stimulating factor (G-CSF) ameliorate acetaminophen-induced hepatotoxicity?
EA Ahmed, AM Abd-Eldayem, E Ahmed
Human & Experimental Toxicology.2021; 40(10): 1755.     CrossRef
Treatment of severe alcoholic hepatitis: A systematic review
Lukas Van Melkebeke, Hannelie Korf, Emmanuel A. Tsochatzis, Schalk van der Merwe, Frederik Nevens, Jef Verbeek
Current Opinion in Pharmacology.2021; 60: 91.     CrossRef